These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 104344)

  • 1. Tolerance to alpha-methyl-p-tyrosine in rats: studies on the antagonism of amphetamine-induced motor activity and excitatory behaviour.
    Widerlöv E; Lewander T
    Psychopharmacology (Berl); 1978 Dec; 60(1):41-5. PubMed ID: 104344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between amphetamine antagonism and depletion of brain catecholamines by alpha-methyl-p-tyrosine in rats.
    Widerlöv E; Lewander T
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):125-34. PubMed ID: 703855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antagonism of D-amphetamine by alpha-methyl-L-tyrosine: behavioral evidence for the participation of catecholamine stores and synthesis in the amphetamine stimulant response.
    Stolk JM; Rech RH
    Neuropharmacology; 1970 May; 9(3):249-63. PubMed ID: 4393182
    [No Abstract]   [Full Text] [Related]  

  • 4. Evidence for presynaptic dopamine mechanisms underlying amphetamine-conditioned locomotion.
    DiLullo SL; Martin-Iverson MT
    Brain Res; 1992 Apr; 578(1-2):161-7. PubMed ID: 1354997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential activity of enantiomers of amphetamine in rats.
    Maickel RP; Light KE; Zabik JE
    Neuropharmacology; 1982 Dec; 21(12):1323-7. PubMed ID: 6218425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential behavioral responses of spontaneously hypertensive (SHR) and normotensive (WKY) rats to d-amphetamine.
    McCarty R; Chiueh CC; Kopin IJ
    Pharmacol Biochem Behav; 1980 Jan; 12(1):53-9. PubMed ID: 6445066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies in mice on the antagonism of (+)-amphetamine anorexia by alpha-methyl-p-tyrosine methyl ester HCl.
    Dobrzański S; Doggett NS
    Neuropharmacology; 1976 Oct; 15(10):619-23. PubMed ID: 1069186
    [No Abstract]   [Full Text] [Related]  

  • 9. Variability in development of tolerance to repeated injections of low doses of dl-amphetamine in rats.
    Thornhill JA; Hirst M; Gowdey CW
    Can J Physiol Pharmacol; 1977 Oct; 55(5):1170-8. PubMed ID: 562704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of ECT on dopaminergic and noradrenergic mechanisms. I. Effect on the behavioural changes induced by reserpine, alpha-methyl-p-tyrosine or amphetamine.
    Papeschi R; Randrup A; Lai S
    Psychopharmacologia; 1974 Feb; 35(2):149-58. PubMed ID: 4856059
    [No Abstract]   [Full Text] [Related]  

  • 11. Antagonism by alpha-methyltyrosine of morphine induced motility in non-tolerant and tolerant rats.
    Davis WM; Babbini M; Khalsa HJ
    Res Commun Chem Pathol Pharmacol; 1972 Sep; 4(2):267-79. PubMed ID: 5074526
    [No Abstract]   [Full Text] [Related]  

  • 12. Ventricular infusion of norepinephrine and amphetamine: direct versus indirect action.
    Segal DS; McAllister C; Geyer MA
    Pharmacol Biochem Behav; 1974; 2(1):79-86. PubMed ID: 4857225
    [No Abstract]   [Full Text] [Related]  

  • 13. Does tolerance develop to low doses of d- and l-amphetamine on locomotor activity in rats?
    Weston PF; Overstreet DH
    Pharmacol Biochem Behav; 1976 Dec; 5(6):645-9. PubMed ID: 1023233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of withdrawal from chronic amphetamine intoxication on exploratory and stereotyped behaviors in the rat.
    Hitzemann RJ; Tseng LF; Hitzemann BA; Sampath-Khanna S; Loh HH
    Psychopharmacology (Berl); 1977 Nov; 54(3):295-302. PubMed ID: 413148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for monoaminergic involvement in triadimefon-induced hyperactivity.
    Crofton KM; Boncek VM; MacPhail RC
    Psychopharmacology (Berl); 1989; 97(3):326-30. PubMed ID: 2497480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. d-Amphetamine-induced anorexia and motor behavior after chronic treatment in rats: relationship with changes in the number of catecholamine receptor sites in the brain.
    Bendotti C; Borsini F; Cotecchia S; De Blasi A; Mennini T; Samanin R
    Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):36-49. PubMed ID: 6962686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rating the behavioral effects of amphetamine.
    Ellinwood EH; Balster RL
    Eur J Pharmacol; 1974 Sep; 28(1):35-41. PubMed ID: 4473346
    [No Abstract]   [Full Text] [Related]  

  • 18. Chronic blockade of neurotensin receptors strongly reduces sensitized, but not acute, behavioral response to D-amphetamine.
    Panayi F; Dorso E; Lambás-Señas L; Renaud B; Scarna H; Bérod A
    Neuropsychopharmacology; 2002 Jan; 26(1):64-74. PubMed ID: 11751033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of a new non-phenylethylamine anorexigenic agent: mazindol.
    Zambotti F; Carruba MO; Barzaghi F; Vicentini L; Groppetti A; Mantegazza P
    Eur J Pharmacol; 1976 Apr; 36(2):405-12. PubMed ID: 945167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced sensitivity to noradrenergic agonists and tolerance development to -methyltyrosine in the rat.
    Beuthin FC; Miya TS; Blake DE; Bousquet WF
    J Pharmacol Exp Ther; 1972 Jun; 181(3):446-56. PubMed ID: 5033011
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.